27.7 C
New York
Wednesday, June 10, 2026

Tag: US70261F1030

newssourceFORcompanyinformationcontent1marketreleases

Pasithea Therapeutics Appoints Expert in ETS2-driven Inflammatory Disease to Scientific Advisory Board

Pasithea adds ETS2 expert Dr. James Lee to its SAB to guide PAS-004 development for IBD and other inflammatory diseases driven by ETS2.

- A word from our sponsors -

spot_img
HomeTagsUS70261F1030

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers